Tissue Analysis Services, Pharma Regulatory Support, Clinical Diagnostics, Diagnostic Biomarker, Drug Development, Scientists, Immuno-Oncology Drug Development, Biomarker Strategy, Companion Diagnostics, CDx, Image Analysis Technology, Global Regulatory Strategy, Accelerate Trials, Companion Diagnostic Biomarker Events Archive - Page 4 of 6

Visit us at ASCO22 | June 3-7 | Booth #16113
Get expert insights on spatial biology & local attractions

CB&CDx – Sept 12, 2019

ANALYTICAL ADVANCEMENTS TO POWER BIOMARKER DEVELOPMENT TRACK PRESENTATION: ADDING VALUE TO TRADITIONAL IN VITRO DIAGNOSTICS (IVDS) AT WORLD CB&CDX September 12, 2019 at 2:50pm The Renaissance Boston

CB&CDx – Sept. 9-12, 2019

WORLD CB AND CDX BOSTON 2019 (CLINICAL BIOMARKER AND COMPANION DIAGNOSTICS) September 9-12, 2019 The Renaissance Boston Waterfront, Boston, MA Flagship Biosciences is a proud Spotlight Partner

Our Services

Pharma

Cell-based image analysis, assays, and partnership to advance clinical trials and regulatory acceptance.

Clinical Diagnostics

Dependable clinical diagnostic testing to connect patients to individualized, immuno-oncology therapies.

Flagship carefully tracks our tissue to ensure we can analyze every assay and stay on schedule.

We are trying to bridge from the discovery stage to clinical development. Flagship's pathologists and scientists provide critical input and the company helps us organize and analyze an incredible amount of data. I highly recommend Flagship for its expertise and support for drug development projects.

During clinical trials, I interact with our manufacturing, legal, pre-clinical, and biomarker teams. Our Flagship project manager understands our tight timeline and ensures delivery of the data we need, when we need it.

We are pleased to partner with Flagship Biosciences to integrate their machine learning/AI tools to provide cancer marker detection.

Flagship’s image analysis experts are flexible and willing to work with us to develop projects that meet the changing needs of our clinical trials drug development.

Flagship has a high reputation as a supplier of advanced IHC services and their CAP-CLIA environment is a perfect complement to our own testing facilities.

The ease of leveraging Flagship’s powerful solution is yet another massive differentiator of the company. Clients need not have to change their existing workflows, investments in technology, or even the assays that they use.

Close Menu

EVENTS

CB&CDx – Sept 12, 2019

CB&CDx – Sept. 9-12, 2019

World CDx 2018

NextGenDx2018

ASCO 2018

AACR 2018

READY TO TAKE THE NEXT STEP?

Our Services

Pharma

Clinical Diagnostics

Related Resources

Blog

Posters & Publications

News

Start Your Consultation Today